Supernus Pharmaceuticals Price to Sales Ratio 2011-2023 | SUPN
Historical PS ratio values for Supernus Pharmaceuticals (SUPN) over the last 10 years. The current P/S ratio for Supernus Pharmaceuticals as of May 02, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Supernus Pharmaceuticals P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-05-02 |
30.27 |
|
2.82 |
| 2023-12-31 |
28.94 |
$10.73 |
2.70 |
| 2023-09-30 |
27.57 |
$10.48 |
2.63 |
| 2023-06-30 |
30.06 |
$10.88 |
2.76 |
| 2023-03-31 |
36.23 |
$11.17 |
3.24 |
| 2022-12-31 |
35.67 |
$11.19 |
3.19 |
| 2022-09-30 |
33.85 |
$11.40 |
2.97 |
| 2022-06-30 |
28.92 |
$10.91 |
2.65 |
| 2022-03-31 |
32.32 |
$10.72 |
3.01 |
| 2021-12-31 |
29.16 |
$10.66 |
2.74 |
| 2021-09-30 |
26.67 |
$10.40 |
2.56 |
| 2021-06-30 |
30.79 |
$10.56 |
2.92 |
| 2021-03-31 |
26.18 |
$10.34 |
2.53 |
| 2020-12-31 |
25.16 |
$9.69 |
2.60 |
| 2020-09-30 |
20.84 |
$8.89 |
2.35 |
| 2020-06-30 |
23.75 |
$7.90 |
3.01 |
| 2020-03-31 |
17.99 |
$7.48 |
2.41 |
| 2019-12-31 |
23.72 |
$7.29 |
3.25 |
| 2019-09-30 |
27.48 |
$7.57 |
3.63 |
| 2019-06-30 |
33.09 |
$7.57 |
4.37 |
| 2019-03-31 |
35.04 |
$7.46 |
4.70 |
| 2018-12-31 |
33.22 |
$7.56 |
4.39 |
| 2018-09-30 |
50.35 |
$7.08 |
7.12 |
| 2018-06-30 |
59.85 |
$6.68 |
8.97 |
| 2018-03-31 |
45.80 |
$6.26 |
7.31 |
| 2017-12-31 |
39.85 |
$5.67 |
7.02 |
| 2017-09-30 |
40.00 |
$5.22 |
7.66 |
| 2017-06-30 |
43.10 |
$4.82 |
8.95 |
| 2017-03-31 |
31.30 |
$4.39 |
7.13 |
| 2016-12-31 |
25.25 |
$4.16 |
6.07 |
| 2016-09-30 |
24.73 |
$3.81 |
6.49 |
| 2016-06-30 |
20.37 |
$3.48 |
5.86 |
| 2016-03-31 |
15.25 |
$3.16 |
4.82 |
| 2015-12-31 |
13.44 |
$2.94 |
4.57 |
| 2015-09-30 |
14.03 |
$2.82 |
4.97 |
| 2015-06-30 |
16.98 |
$2.59 |
6.55 |
| 2015-03-31 |
12.09 |
$2.61 |
4.64 |
| 2014-12-31 |
8.30 |
$2.19 |
3.79 |
| 2014-09-30 |
8.69 |
$1.77 |
4.90 |
| 2014-06-30 |
10.95 |
$1.29 |
8.51 |
| 2014-03-31 |
8.94 |
$0.59 |
15.03 |
| 2013-12-31 |
7.54 |
$0.38 |
19.90 |
| 2013-09-30 |
7.33 |
$0.12 |
62.66 |
| 2013-06-30 |
6.43 |
$0.08 |
80.30 |
| 2013-03-31 |
5.62 |
$0.08 |
73.57 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.664B |
$0.608B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
